These final results, along with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 help the strategy of concentrating on ACKR3 as a novel approach to modulate the opioid technique, which could open new therapeutic avenues for opioid-linked disorders. This information and facts https://herbertv903axn0.blazingblog.com/profile